|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2004-2-11
|
|
pubmed:abstractText |
Predicting factors for the outcome of conventional Helicobacter pylori triple therapy have been identified. Of these, the presence of the CagA gene is a strong predictor of successful treatment. Our preliminary data show that this factor becomes irrelevant when sequential therapy is used.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo...,
http://linkedlifedata.com/resource/pubmed/chemical/Amoxicillin,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Bacterial,
http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Clarithromycin,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole,
http://linkedlifedata.com/resource/pubmed/chemical/Tinidazole,
http://linkedlifedata.com/resource/pubmed/chemical/VacA protein, Helicobacter pylori,
http://linkedlifedata.com/resource/pubmed/chemical/cagA protein, Helicobacter pylori,
http://linkedlifedata.com/resource/pubmed/chemical/rabeprazole
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
pubmed-author:BaroneMM,
pubmed-author:BerlocoPP,
pubmed-author:BurattiniOO,
pubmed-author:De FrancescoVV,
pubmed-author:Di LeoAA,
pubmed-author:FrancavillaAA,
pubmed-author:IerardiEE,
pubmed-author:MarangiSS,
pubmed-author:MargiottaMM,
pubmed-author:MinennaM FMF,
pubmed-author:MoriniSS,
pubmed-author:PanellaCC,
pubmed-author:RussoFF,
pubmed-author:StoppinoVV,
pubmed-author:ZulloAA
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
407-14
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14871280-2-Pyridinylmethylsulfinylbenzimidazoles,
pubmed-meshheading:14871280-Adult,
pubmed-meshheading:14871280-Amoxicillin,
pubmed-meshheading:14871280-Anti-Bacterial Agents,
pubmed-meshheading:14871280-Anti-Ulcer Agents,
pubmed-meshheading:14871280-Antigens, Bacterial,
pubmed-meshheading:14871280-Bacterial Proteins,
pubmed-meshheading:14871280-Benzimidazoles,
pubmed-meshheading:14871280-Clarithromycin,
pubmed-meshheading:14871280-DNA,
pubmed-meshheading:14871280-Drug Evaluation,
pubmed-meshheading:14871280-Drug Therapy, Combination,
pubmed-meshheading:14871280-Dyspepsia,
pubmed-meshheading:14871280-Female,
pubmed-meshheading:14871280-Helicobacter Infections,
pubmed-meshheading:14871280-Helicobacter pylori,
pubmed-meshheading:14871280-Humans,
pubmed-meshheading:14871280-Male,
pubmed-meshheading:14871280-Middle Aged,
pubmed-meshheading:14871280-Omeprazole,
pubmed-meshheading:14871280-Peptic Ulcer,
pubmed-meshheading:14871280-Polymerase Chain Reaction,
pubmed-meshheading:14871280-Risk Factors,
pubmed-meshheading:14871280-Smoking,
pubmed-meshheading:14871280-Tinidazole,
pubmed-meshheading:14871280-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure.
|
|
pubmed:affiliation |
Gastroenterology Unit, Ospedali Riuniti, Foggia, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
